MarketPeel
Insider Trading Intelligence
JH

John Hamer

ABCL
DIRECTOR · ABCELLERA BIOLOGICS INC. · CIK 0001198174
FILING MIX · LIFETIME40%/60%
BUYS
4
SELLS
6
TOTAL VALUE
$5.08M
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
128,862
AVG SELL PX
$16.94
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John Hamer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+10.34%-0.11%+10.45%+10.45%
14d2+0.00%+7.88%-1.25%+9.13%+9.13%
30d2+0.00%+10.51%-4.12%+14.63%+14.63%
60d2+50.00%-2.89%+2.09%-4.98%-4.98%
90d2+100.00%-13.80%+2.19%-15.99%-15.99%
180d2+100.00%-48.32%-2.68%-45.64%-45.64%
1y2+100.00%-35.48%-11.13%-24.36%-24.36%
2y2+100.00%-67.25%+2.87%-70.12%-70.12%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABCL · 128,862 shares · as of Sep 1, 2021
07,276,44014,552,88121,829,32129,105,7612021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
FLOW · 4 buys / 6 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABCL
ABCELLERA BIOLOGICS INC.
SALE
137,351$16.93$2.33M128,862Sep 1, 2021Sep 2, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
162,649$16.95$2.76M266,213Aug 31, 2021Sep 2, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
73,89273,892Jun 18, 2021Jun 22, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
5,000,00024,105,761Jun 18, 2021Jun 22, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
0Dec 15, 2020Dec 17, 2020View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
29,076,35029,076,350Dec 15, 2020Dec 17, 2020View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
802,3710Dec 15, 2020Dec 17, 2020View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
2,105,2640Dec 15, 2020Dec 17, 2020View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
29,41129,105,761Dec 15, 2020Dec 17, 2020View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
$500,000.00Dec 11, 2020Dec 17, 2020View →
Other insiders · ABCL
Loading peer insiders…
About this filer
CIK 0001198174
ROLE
Director
PRIMARY
ABCL
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001198174DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback